North American Market for CTC Diagnostics Accounts for Nearly One-Third Revenue Share of the Global Market – Fact.MR Study

Circulating tumor cells (CTCs) are today a hot pursuit in the area of cancer research, diagnostics, and treatment as their self-renewal capabilities are one of the primary causes of tumorigenesis. The use of CTC diagnostic tests is picking pace owing to their accuracy and reliability in identifying the risks of cancer as well as in monitoring various cancer treatments.

Furthermore, a mounting number of end users including hospitals, diagnostic centers, research and academic institutes, and oncology labs, are aiming to collaborate with manufacturers in the CTC diagnostics to ensure the availability of high-tech and next-generation cancer diagnostic tools and equipment for improved patient outcomes.

This is one of the most important factors that are providing an impetus to the impressive growth of the global circulating tumor cells market.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=5510

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of CTC Diagnostics market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of CTC Diagnostics

The report offers actionable and valuable market insights of CTC Diagnostics. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of CTC Diagnostics Market across various industries and regions

Circulating tumor cells (CTCs) are today a hot pursuit in the area of cancer research, diagnostics, and treatment as their self-renewal capabilities are one of the primary causes of tumorigenesis. The use of CTC diagnostic tests is picking pace owing to their accuracy and reliability in identifying the risks of cancer as well as in monitoring various cancer treatments.

Why Demand for Diagnostic Kits and Reagents is Key?
The CTC diagnostics market is witnessing impressive growth with the rising demand for these diagnostic devices across various cancer research and diagnosis centers.

While the adoption of CTC diagnostic devices and systems is most common across end users, the demand for diagnostic kits and reagents is expected to pick pace in the coming years.

The convenience of using CTC testing kits and reagents along with their performance in such diagnostic procedures is one of the primary factors that are triggering the shift from diagnostic devices and systems. This trend in the CTC diagnostics market is expected to remain popular in the coming years.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=5510

CTC Diagnostics Market: Segmentation
The study offers a detailed estimation and outlook of the CTC diagnostics market based on the product, technology, application, sample type, and region.

Product
• Devices & Systems
• Kits & Reagents
• Other Consumables

Technology
• CTC Enrichment Methods
• CTC Detection Methods
• CTC Analysis

Application
• Cancer Stem Cell Research
• EMT Biomarkers Development
• Tumorigenesis Research
• Others

Sample Type
• Blood
• Bone Marrow
• Others

Region
• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa

What are the Key Strategies of Circulating Tumor Cells Market Players
Key players in the CTC diagnostics market include
• Qiagen
• Bio-Techne Corporation
• Janssen Diagnostics LLC
• Advanced cell Diagnostics Inc
• ApoCell Inc
• Celltraffix Inc.
• Aviva Biosciences
• Biocept Inc
• Clearbridge Biomedics
• Fluxion Biosciences
• IVDiagnostics
• Stemcell Technologies Inc
• Stemcell Technologies Inc.
• Sysmex Corporation. Leading

Leading market players are increasing their focus on research and development as innovation remains an integral part of their business strategy to gain an edge in this landscape.

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/5510

Key Takeaways from CTC Diagnostics Market Report
• The CTC diagnostics market has surpassed the mark of US$ 6 billion, as it reached the valuation of US$ 6.3 billion in 2020. The primary factor to drive the market remains the ongoing research in the field of cancer diagnostics and alarmingly increasing number of cancer deaths around the world.
• The market is expected to witness exponential growth in the coming decade as the projected CAGR is likely to exceed beyond 17% during the forecast period of 2020 to 2030.
• The adoption of CTC enrichment methods is likely to remain significantly high, as the segment is projected to reach the valuation of over US$ 9.5 billion by the end of the assessment period.
• The North American market for CTC diagnostics is expected to lead the regional category with a valuation of over US$ 2 billion in 2020. With the ongoing cancer research in the region and growing presence of market leaders, the regional market is expected to secure one-third revenue share in the global space.
• Patients’ inclination towards non-invasive diagnostics tests and prognostic tools for predicting or detecting the risks of cancer is one of the driving forces for the growth of the market. Manufacturers are also expected to experiment around technologies for detection and analyzing CTCs to improve accuracy and reliability of results.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – https://www.factmr.com/report/fluoro-enzymatic-assays-market

Shower Chairs Market – https://www.factmr.com/report/shower-chairs-market

Infrared Thermometer Market – https://www.factmr.com/report/infrared-thermometer-market

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.